Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.045 CAD
−4.31 M CAD
1.02 M CAD
110.63 M
About RAPID DOSE THERAPEUTICS CORP.
Sector
Industry
CEO
Mark Upsdell
Website
Headquarters
Burlington
Founded
2008
FIGI
BBG00MTJ0588
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company, which engages in providing innovative, proprietary, and drug-delivery technologies designed to improve outcomes and quality of lives. It owns a proprietary oral fast dissolving drug delivery system, QuickStrip. It operates through the following business segments: Health and Wellness, White Label, and MSSA. The Health and Wellness segment includes nutraceuticals and infused soaps. The White Label segment refers to the selling of oral thin film strips containing active ingredients under cannabis licensing. The MSSA segment is involved in MSSA contracts, and licensing and other related services. The company was founded by Mark Upsdell on February 27, 2008 and is headquartered in Burlington, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DOSE is 0.275 CAD — it has decreased by −5.17% in the past 24 hours. Watch RAPID DOSE THERAPEUTICS CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange RAPID DOSE THERAPEUTICS CORP. stocks are traded under the ticker DOSE.
DOSE stock has fallen by −1.79% compared to the previous week, the month change is a 27.91% rise, over the last year RAPID DOSE THERAPEUTICS CORP. has showed a 71.88% increase.
DOSE reached its all-time high on Jan 4, 2019 with the price of 1.330 CAD, and its all-time low was 0.070 CAD and was reached on Aug 25, 2022. View more price dynamics on DOSE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DOSE stock is 9.26% volatile and has beta coefficient of −0.47. Track RAPID DOSE THERAPEUTICS CORP. stock price on the chart and check out the list of the most volatile stocks — is RAPID DOSE THERAPEUTICS CORP. there?
Today RAPID DOSE THERAPEUTICS CORP. has the market capitalization of 34.27 M, it has increased by 16.67% over the last week.
Yes, you can track RAPID DOSE THERAPEUTICS CORP. financials in yearly and quarterly reports right on TradingView.
RAPID DOSE THERAPEUTICS CORP. is going to release the next earnings report on Feb 3, 2025. Keep track of upcoming events with our Earnings Calendar.
DOSE net income for the last quarter is −1.10 M CAD, while the quarter before that showed −1.26 M CAD of net income which accounts for 12.61% change. Track more RAPID DOSE THERAPEUTICS CORP. financial stats to get the full picture.
No, DOSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RAPID DOSE THERAPEUTICS CORP. EBITDA is −3.38 M CAD, and current EBITDA margin is −241.37%. See more stats in RAPID DOSE THERAPEUTICS CORP. financial statements.
Like other stocks, DOSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAPID DOSE THERAPEUTICS CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAPID DOSE THERAPEUTICS CORP. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAPID DOSE THERAPEUTICS CORP. stock shows the buy signal. See more of RAPID DOSE THERAPEUTICS CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.